ArticleCurrent oncology (Toronto, Ont.)2022

Clinical Factors Associated with Long-Term Survival in Metastatic Melanoma Treated with Anti-PD1 Alone or in Combination with Ipilimumab.

Siddhartha Goutam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.